The effect of intravitreal bevacizumab (Avastin^®) on ocular pulse amplitude in neovascular age-related macular degeneration

References

• Saint-GeniezMMaldonadoAED’AmorePAVEGF expression and receptor activation in the choroid during development and in the adultInvest Ophthalmol Vis Sci20064773135314216799060
   PubMed Web of Science ®Google Scholar
• MarnerosAGFanJYokoyamaYVascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual functionAm J Pathol200516751451145916251428
   PubMed Web of Science ®Google Scholar
• BökerTFangTSteinmetzRRefractive error and choroidal perfusion characteristics in patients with choroidal neovascularization and age-related macular degenerationGer J Ophthalmol19932110137679594
   PubMedGoogle Scholar
• RemullaJGaudioAMillerSSandbergMAFoveal electroretinograms and choroidal perfusion characteristics in fellow eyes of patients with unilateral neovascular age-related macular degenerationBr J Ophthalmol19957965585617542915
   PubMed Web of Science ®Google Scholar
• ZhaoJFrambachDLeePPLeeMLopezPFDelayed macular choriocapillary circulation in age-related macular degenerationInt Ophthalmol19951911128537189
   PubMed Web of Science ®Google Scholar
• ChenJCFitzkeFWPauleikhoffDBirdACFunctional loss in age-related Bruch’s membrane change with choroidal perfusion defectInvest Ophthalmol Vis Sci19923323343401740363
   PubMed Web of Science ®Google Scholar
• PauleikhoffDChenJCChisholmIHBirdACChoroidal perfusion abnormality with age-related Bruch’s membrane changeAm J Ophthalmol199010922112172301534
   PubMed Web of Science ®Google Scholar
• PiguetBPalmvangIBChisholmIHMinassianDBirdACEvolution of age-related macular degeneration with choroidal perfusion abnormalityAm J Ophthalmol199211366576631598956
   PubMed Web of Science ®Google Scholar
• GrunwaldJEHariprasadSMDuPontJFoveolar choroidal blood flow in age-related macular degenerationInvest Ophthalmol Vis Sci19983923853909477998
   PubMed Web of Science ®Google Scholar
• FriedmanEKrupskySLaneAMOcular blood flow velocity in age-related macular degenerationOphthalmology199510246406467724181
   PubMed Web of Science ®Google Scholar
• CiullaTAHarrisAChungHSColor Doppler imaging discloses reduced ocular blood flow velocities in nonexudative age-related macular degenerationAm J Ophthalmol19991281758010482097
   PubMed Web of Science ®Google Scholar
• MoriFKonnoSHikichiTYamaguchiYIshikoSYoshidaAPulsatile ocular blood flow study: decreases in exudative age-related macular degenerationBr J Ophthalmol200185553153311316708
   PubMed Web of Science ®Google Scholar
• SpraulCWLangGERonzaniMHögelJLangGKReproducibility of measurements with a new slit lamp-mounted ocular blood flow tonographGraefes Arch Clin Exp Ophthalmol199823642742799561360
   PubMed Web of Science ®Google Scholar
• AlmABillAOcular circulationMosesRHatWAdler’s Physiology of the EyeSt Louis (MO)Mosby19926
   Google Scholar
• LanghamMEFarrellRAO’BrienVNoninvasive measurement of pulsatile blood flow in the human eyeLambrouGNGreveELOcular Blood Flow in GlaucomaAmsterdamKugler and Ghedini1989
   Google Scholar
• FunkMKarlDGeorgopoulosMNeovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumabOphthalmology2009116122393239919815292
   PubMed Web of Science ®Google Scholar
• RohMILimSJAhnJMLimJBKwonOWConcentration of cytokines in age-related macular degeneration after consecutive intravitreal bevacizumab injectionGraefes Arch Clin Exp Ophthalmol2010248563564019997926
   PubMed Web of Science ®Google Scholar
• BakriSJSnyderMRReidJMPharmacokinetics of intravitreal bevacizumab (Avastin)Ophthalmology20071141285585917467524
   PubMed Web of Science ®Google Scholar
• ZhuQZiemssenFHenke-FahleSVitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularizationOphthalmology2008115101750175518708261
   PubMed Web of Science ®Google Scholar
• CsakyKGGordiyenkoNRabenaMGAveryRLInvest Ophthalmol Vis Sci200748 ARVO E-Abstract 4936
   Google Scholar
• BoltzALukschAWimpissingerBChoroidal blood flow and progression of age-related macular degeneration in the fellow eye in patients with unilateral choroidal neovascularizationInvest Ophthalmol Vis Sci20105184220422520484590
   PubMed Web of Science ®Google Scholar
• AdamisAPShimaDTThe role of vascular endothelial growth factor in ocular health and diseaseRetina200525211111815689799
   PubMed Web of Science ®Google Scholar
• FerraraNDamicoLShamsNLowmanHKimRDevelopment of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degenerationRetina200626885987017031284
   PubMed Web of Science ®Google Scholar
• YuanFChenYDellianMSafabakhshNFerraraNJainRKTime-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibodyProc Natl Acad Sci U S A1996932514765147708962129
   PubMed Web of Science ®Google Scholar
• KambaTTamBYHashizumeHVEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculatureAm J Physiol Heart Circ Physiol20062902H560H57616172168
   PubMed Web of Science ®Google Scholar
• InaiTMancusoMHashizumeHInhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghostsAm J Pathol20041651355215215160
   PubMed Web of Science ®Google Scholar
• MordentiJCuthbertsonRAFerraraNComparisons of the intraocular tissue distribution, pharmacokinetics, and safety of 125I labeled full-length and Fab antibodies in rhesus monkeys following intravitreal administrationToxicol Pathol199927553654410528633
   PubMed Web of Science ®Google Scholar
• ShaharJAveryRLHeilweilGElectrophysiologic and retinal penetration studies following intravitreal injection of bevacizumab (Avastin)Retina200626326226916508424
   PubMed Web of Science ®Google Scholar
• HeiduschkaPFietzHHofmeisterSPenetration of bevacizumab through the retina after intravitreal injection in the monkeyInvest Ophthalmol Vis Sci20074862814282317525217
   PubMed Web of Science ®Google Scholar
• PieramiciDJRabenaMDAnti-VEGF therapy: comparison of current and future agentsEye (Lond)200822101330133618497829
   PubMed Web of Science ®Google Scholar
• PetersSHeiduschkaPJulienSUltrastructural findings in the primate eye after intravitreal injection of bevacizumabAm J Ophthalmol20071436995100217449002
   PubMed Web of Science ®Google Scholar
• GibranSKSachdevAStapplerTNewsomeRWongDHiscottPHistological findings of a choroidal neovascular membrane removed at the time of macular translocation in a patient previously treated with intravitreal bevacizumab treatment (Avastin)Br J Ophthalmol200791560260417166893
   PubMed Web of Science ®Google Scholar
• Comparison of age-related macular degeneration treatments trials: Lucentis-Avastin trial (CATT). ClinicalTrials.gov identifier: NCT00593450.
   Google Scholar
• BoehmAGWeberAPillunatLEKochRSpoerlEDynamic contour tonometry in comparison to intracameral IOP measurementsInvest Ophthalmol Vis Sci20084962472247718316699
   PubMed Web of Science ®Google Scholar
• KaufmannCBachmannLMThielMAComparison of dynamic contour tonometry with Goldmann applanation tonometryInvest Ophthalmol Vis Sci20044593118312115326129
   PubMed Web of Science ®Google Scholar
• HalkiadakisIPatseaEChatzimichaliKComparison of dynamic contour tonometry with Goldmann applanation tonometry in glaucoma practiceActa Ophthalmol200987332332818631335
   PubMed Web of Science ®Google Scholar
• BarleonLHoffmannEMBerresMPfeifferNGrusFHComparison of dynamic contour tonometry and Goldmann applanation tonometry in glaucoma patients and healthy subjectsAm J Ophthalmol2006142458359017011849
   PubMed Web of Science ®Google Scholar
• KaufmannCBachmannLMRobertYCThielMAOcular pulse amplitude in healthy subjects as measured by dynamic contour tonometryArch Ophthalmol200612481104110816908812
   PubMedGoogle Scholar
• GrieshaberMCKatamayRGugletaKKochkorovAFlammerJOrgülSRelationship between ocular pulse amplitude and systemic blood pressure measurementsActa Ophthalmol200987332933418937813
   PubMed Web of Science ®Google Scholar
• RomppainenTKniestedtCBachmannLMStürmerJOcular pulse amplitude: a new biometrical parameter for the diagnose of glaucoma? [German]Ophthalmologe2007104323023517323044
   PubMed Web of Science ®Google Scholar
• Benavente-PérezAHoskingSLLoganNSBroadwayDCOcular blood flow measurements in healthy human myopic eyesGraefes Arch Clin Exp Ophthalmol2010248111587159420502909
   PubMed Web of Science ®Google Scholar
• McBrienNAGentleARole of the sclera in the development and pathological complications of myopiaProg Retin Eye Res200322330733812852489
   PubMed Web of Science ®Google Scholar
• PallikarisIGKymionisGDGinisHSKounisGATsilimbarisMKOcular rigidity in living human eyesInvest Ophthalmol Vis Sci200546240941415671262
   PubMed Web of Science ®Google Scholar
• FriedmanEIvryMEbertEGlynnRGragoudasESeddonJIncreased scleral rigidity and age-related macular degenerationOphthalmology19899611041082919041
   PubMed Web of Science ®Google Scholar
• StalmansIHarrisAVanbellinghenVZeyenTSieskyBOcular pulse amplitude in normal tension and primary open angle glaucomaJ Glaucoma200817540340718703952
   PubMed Web of Science ®Google Scholar
• HarrisACiullaTAPrattLMThe effects of dorzolamide on choroidal and retinal perfusion in non-exudative age related macular degenerationBr J Ophthalmol200387675375712770975
   PubMed Web of Science ®Google Scholar
• Zayit-SoudrySZemelELoewensteinAPerlmanISafety evaluation of repeated intravitreal injections of bevacizumab and ranibizumab in rabbit eyesRetina201030467168119952984
   PubMed Web of Science ®Google Scholar
• PedersenKBMøllerFSjølieAKAndréassonSElectrophysiological assessment of retinal function during 6 months of bevacizumab treatment in neovascular age-related macular degenerationRetina20103071025103320616681
   PubMed Web of Science ®Google Scholar
• AdelmanRAZhengQMayerHRPersistent ocular hypertension following intravitreal bevacizumab and ranibizumab injectionsJ Ocul Pharmacol Ther201026110511020187807
   PubMed Web of Science ®Google Scholar
• GoodTJKimuraAEMandavaNKahookMYSustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agentsBr J Ophthalmol2010Aug 11 102174/1874364101004010028 [Epub ahead of print]
   Web of Science ®Google Scholar